Skip to content

Acute Cardiovascular Responses and Chronic Adaptations of Strength Exercise in Intermittent Claudication Patients

Acute Cardiovascular Responses and Chronic Adaptations of Strength Exercise in Intermittent Claudication Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02778568
Enrollment
30
Registered
2016-05-20
Start date
2010-01-31
Completion date
2015-12-31
Last updated
2016-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intermittent Claudication, Peripheral Artery Disease

Brief summary

The aim of this study was to analyze the effects of resistance exercise and training on cardiovascular function of peripheral artery disease patients.

Detailed description

Several studies have shown that strength training can promote important benefits for the cardiovascular system in healthy subjects and patients with chronic diseases. However, the effects of resistance exercise on cardiovascular function in intermittent claudication patients are unclear. In addition, it also do not know the chronic effects on cardiovascular function in these patients.

Interventions

BEHAVIORALResistance training

Resistance training exercises

BEHAVIORALControl

Stretching exercises

Sponsors

Fundação de Amparo à Ciência e Tecnologia de Pernambuco
CollaboratorOTHER
Conselho Nacional de Desenvolvimento Científico e Tecnológico
CollaboratorOTHER_GOV
University of Pernambuco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Had a graded treadmill test that was limited by claudication (2 minutes) * Had an ankle brachial index \<0.90 * Had systolic blood pressure ,160 mmHg and/or diastolic blood pressure,105 mmHg * Were not performing any regular exercise program * Were not using antihypertensive medications affecting the heart rate (e.g., b-blockers and nondihydropyridine calcium channel blockers) * Were nonobese * Individuals who have not undergone bypass surgery or angioplasty least one year ago

Exclusion criteria

* Had no symptoms related to myocardial ischemia during the treadmill test * Amputation

Design outcomes

Primary

MeasureTime frame
Change in blood pressureChange from baseline to 12 and 24 weeks

Secondary

MeasureTime frameDescription
Change in Health related Quality of lifeChange from baseline to 12 and 24 weeksBaseline, 12 wks and 24 wks
Change in Muscle blood flow of limbsChange from baseline to 12 and 24 weeksMuscle blood flow assessed with venous occlusion plethysmography
Change in body fatChange from baseline to 12 and 24 weeks
Change in Walking distanceChange from baseline to 12 and 24 weeks
Change in serum glucoseChange from baseline to 12 and 24 weeks
Change in TNFalphaChange from baseline to 12 and 24 weeks
Change in Score Short-physical performance batteryChange from baseline to 12 and 24 weeks
Change Serum CholesterolChange from baseline to 12 and 24 weeks

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026